Pier 88 Investment Partners LLC Makes New Investment in Iovance Biotherapeutics, Inc. (NASDAQ:IOVA)

Pier 88 Investment Partners LLC bought a new stake in shares of Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 27,290 shares of the biotechnology company’s stock, valued at approximately $222,000. A […]

Related Keywords

United States ,Iovance Biotherapeutics ,Investment Partners ,Iovance Biotherapeutics Company Profile ,Norges Bank ,Iovance Biotherapeutics Inc ,Nasdaq ,Exchange Commission ,Goldman Sachs Group ,Wells Fargo Company ,Corient Private Wealth ,Roanoke Asset Management Corp ,Panagora Asset Management Inc ,Free Report ,Private Wealth ,Asset Management Corp ,Panagora Asset Management ,Asset Management ,Chardan Capital ,Get Free Report ,